Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. - Wikidata - wikimedia - TriplyDB

Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization.

Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization.

http://www.wikidata.org/entity/Q33252805

about

Alternative pathways in the development of diabetic retinopathy: the renin-angiotensin and kallikrein-kinin systems Suppression of experimental choroidal neovascularization by curcumin in mice Role of the immune system in hypertension: modulation by dietary antioxidants.Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system.A Novel Single-Strand RNAi Therapeutic Agent Targeting the (Pro)renin Receptor Suppresses Ocular Inflammation.Role of IL-6 in angiotensin II-induced retinal vascular inflammation.A glimpse at the aging eye.Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes Neuroprotective response after photodynamic therapy: role of vascular endothelial growth factor Blockade of vascular adhesion protein-1 attenuates choroidal neovascularization.Angiotensin II-related hypertension and eye diseases.Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host disease A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis.Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: implications for age-related macular degene Intravitreal injection of (99)Tc-MDP inhibits the development of laser-induced choroidal neovascularization in rhesus monkeys.Research resource: nuclear receptor atlas of human retinal pigment epithelial cells: potential relevance to age-related macular degeneration PPARgamma Agonists: Potential as Therapeutics for Neovascular Retinopathies Vascular adhesion protein-1 blockade suppresses choroidal neovascularization.Vascular adhesion protein 1 in the eye.Prorenin and the (pro)renin receptor in ocular pathology Anti-inflammatory activity of telmisartan in rat models of experimentally-induced chronic inflammation: Comparative study with dexamethasone.Angiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleen.Angiotensin II type 2 receptor blockade increases bone mass.Hydration, fluid regulation and the eye: in health and disease.Multivalent targeting of AT1 receptors with angiotensin II-functionalized nanoparticles.Expression of classical components of the renin-angiotensin system in the human eye.Therapeutic targets of renin-angiotensin system in ocular disorders.Many Faces of Renin-angiotensin System - Focus on Eye.Relationships of orientation discrimination threshold and visual acuity with macular lesions in age-related macular degeneration.Effect of candesartan on the expression of sclera-choroidal intercellular adhesion molecule-1 in hypercholesterolemic models.Renin-Angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction.(Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy.Investigation of the effect of telmisartan on experimentally induced peripheral nerve injury in rats.Telmisartan ameliorates oxidative stress and subarachnoid haemorrhage-induced cerebral vasospasm.Receptor-associated prorenin system contributes to development of inflammation and angiogenesis in proliferative diabetic retinopathy.Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.

P2860

Q27025635-D8B5E975-CF5D-4FB8-A6CC-38C8C061275A Q28484654-01361BE1-AED5-4400-AEE5-F1D0964FE75A Q30424339-7DFA18B9-B3D3-4836-881F-0943FEE51594 Q33285746-9FE09834-CE33-4B61-8FE5-1B026042DCAD Q33381492-52552C3E-05A1-4008-A719-10B3DDD420AB Q33635383-14DC9DC0-EDF3-492C-AF8E-84CE380B8104 Q33845139-BFA88AA5-50A4-414D-BDB6-65008B00FE37 Q33914344-165820F9-0341-449D-BC25-5CB508C92BC1 Q34087095-9376244C-589A-407B-968B-EB75264C76C1 Q34101883-B238734E-AF6F-4C6B-B295-4AFBE6278C1F Q34196720-D0FFBC15-8E4B-40EC-9979-01B800E5D335 Q34251889-3E649624-FEF1-4B18-A7BF-69E091C7351F Q34518507-9759124D-EA1A-4A2B-9EF9-8DC446FB08AA Q34769458-3F72B62C-E149-410D-BDC7-4E955F3F3C30 Q34797862-63D57C59-D706-460F-8836-DEC6C7831C35 Q35071068-0E156B0D-E518-4E7E-9460-B16D491FF406 Q35081925-E15A7AB4-DF71-4C9A-B1BA-A5205F6AC71A Q36067442-43B7E59E-8D48-4E99-B07B-09D765E47D9D Q36676571-E96BD52A-9320-45CF-91BB-34B1C49515B7 Q36804945-D410948E-E6B1-4944-A325-09B9CEB8CFFE Q36942812-04E79585-00B7-46FF-9107-C7D4CA0F2962 Q37061060-71C4EC2C-33AA-470D-A196-0D3F032F10D4 Q37099273-616498E8-CDDA-41A4-A5CF-248BDEF1A693 Q37210914-26C42796-767F-44F0-99B1-719BE7DF4500 Q37344123-70506FC2-AA9B-457E-9022-7ED6557FF698 Q38464030-975E9CEA-74D0-4426-87E3-C72F62492961 Q38878171-B60D34BC-9465-429E-AFC0-99399AC807FF Q38950146-C8F16C60-6D70-461B-ACB1-A3429C5F942A Q39214578-922E2A20-DD47-412F-B113-0D05F47079AC Q41015495-C63655FB-AE79-4F2C-9534-2EA11193D357 Q41702424-4FC8C65C-0777-45BE-97B4-B182148AE11A Q41870370-67A04C07-EAD4-42FA-93E6-E0E3F3C88942 Q42098043-1F5FB9C2-B11B-424D-8A62-D1A93AE7F226 Q43797341-34432706-5BC8-4D31-BD85-EB9CC444D390 Q46188427-322F4FF4-1C0C-4FDD-B006-1047072A84B6 Q46563599-788CF148-2630-4E0D-A935-43BDF8F59736 Q47115372-343B0FEC-668E-4558-B4F2-FD07E61F2032 Q51157373-0F5C4806-0BA2-4FF5-9CBA-AAC6F9466E3C

P2860

Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization.

http://www.wikidata.org/entity/Q33252805

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Angiotensin II type 1 receptor ...... choroidal neovascularization.

@ast

Angiotensin II type 1 receptor ...... choroidal neovascularization.

@en

type

label

Angiotensin II type 1 receptor ...... choroidal neovascularization.

@ast

Angiotensin II type 1 receptor ...... choroidal neovascularization.

@en

prefLabel

Angiotensin II type 1 receptor ...... choroidal neovascularization.

@ast

Angiotensin II type 1 receptor ...... choroidal neovascularization.

@en

P1433

Q33252805-98000EE3-74B4-43C1-B4D3-7BBA88D15BBA

P1476

Q33252805-82596DD6-96C7-44AE-B91C-342A0F7B57C0

P2093

Q33252805-123E2B15-A54D-43F2-8CB8-4F69C2B289B9

Q33252805-133787B9-67C2-402E-9F14-5BF3BC3345E9

Q33252805-1F7CB141-D0FD-48B0-B08D-34C53235C472

Q33252805-233F7A1E-F9F0-44C7-B2FA-97B3A1146965

Q33252805-58E4542B-5A1C-41EB-B893-D4D3465F6E53

Q33252805-61470031-F177-450B-80B2-91196D1AA725

Q33252805-7777DEAC-3694-46C7-B565-957E9CC7B1F0

Q33252805-853E29B5-371D-4805-A1C2-5FFFC6063E6B

Q33252805-86E2F209-941C-421B-9099-FFD86B9D6BA6

Q33252805-9E806B68-73B6-40AA-B6F1-227B5C1DD54B

P304

Q33252805-C6FD7A4E-197C-4D3D-ADAE-DDFE3E3A08CD

P31

Q33252805-7D808347-2244-420A-84A8-768A90AA8106

P356

Q33252805-01DEE51B-79DA-47C3-AE2C-6F4970542402

P407

Q33252805-2B2FB953-7C86-499D-8008-A91A05C08AEE

P433

Q33252805-7E307126-748E-4CB5-9883-4AAD74DD5B5E

P478

Q33252805-119DF157-BBF8-47AE-BD8B-A7F479DCDB60

P50

Q33252805-DD412926-59A7-4F99-B682-BF9BD63005C1

P577

Q33252805-E96829EC-42B3-49AF-A021-FB7FB6424721

P698

Q33252805-E386946B-5CC0-45CC-9FD0-92CEF5179948

P921

Q33252805-674358FB-6AFD-40F4-9141-61DF5C7103D8

Q33252805-A0CA1BC0-5A6E-4757-90D7-C745F1225D4D

P356

01.ATV.0000240050.15321.FE

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Angiotensin II type 1 receptor ...... choroidal neovascularization.

@en

P2093

Kanako Izumi-Nagai

http://www.w3.org/2001/XMLSchema#string

Kazuo Tsubota

http://www.w3.org/2001/XMLSchema#string

Kousuke Noda

http://www.w3.org/2001/XMLSchema#string

Makoto Inoue

http://www.w3.org/2001/XMLSchema#string

Norihiro Nagai

http://www.w3.org/2001/XMLSchema#string

Susumu Ishida

http://www.w3.org/2001/XMLSchema#string

Takashi Urano

http://www.w3.org/2001/XMLSchema#string

Yoko Ozawa

http://www.w3.org/2001/XMLSchema#string

Yoshiaki Kubota

http://www.w3.org/2001/XMLSchema#string

Yuichi Oike

http://www.w3.org/2001/XMLSchema#string

P304

2252-2259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.ATV.0000240050.15321.FE

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16888236

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization